Henry Schein (HSIC) beat expectations in Q2 FY2026 on revenue of $3.5B versus the $3.4B estimate (+6.7% YoY) and EPS of $1.27. The next Henry Schein (HSIC) earnings date is Nov 3, 2026. Below is the full Henry Schein earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Henry Schein (HSIC) Earnings Analysis — key stats
Next earnings date
Nov 3, 2026
Latest reported quarter
Q2 FY2026
Earnings verdict
Beat
EPS beat rate
6 of last 8 (quarters above estimate)
Avg next-day move
±4.2% (over the last 8 reports)
Post-earnings direction
Up 5 / Down 3 (of the last 8 reports)
Implied move (next report)
±3.2% (options-derived · into Nov 3, 2026)
Institutional ownership
109.2% (13F as of 2026-06-30)
Top 10 holders
55.2% (of shares outstanding)
Insider activity
2 buys / 6 sells (recent Form 4 filings)
Revenue
$3.5B (vs $3.4B est · +2.5% surprise · +6.7% YoY)
EPS
$1.27 (vs $1.24 est · +2.4% surprise · +16.9% YoY)
Share price
$85.21 (-0.9%)
Market cap
$9.5B
Henry Schein (HSIC) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q3 FY2026
$3.5B vs $3.4B est
$1.27 vs $1.24 est
+2.4%
+3.6%
Beat
Q2 FY2026
$3.4B vs $3.3B est
$1.32 vs $1.20 est
+10.0%
+0.6%
Mixed
Q1 FY2026
$3.4B vs $3.3B est
$1.34 vs $1.30 est
+3.1%
+1.7%
Beat
Q4 FY2025
$3.3B vs $3.3B est
$1.38 vs $1.27 est
+8.7%
+11.4%
Mixed
Q3 FY2025
$3.2B vs $3.3B est
$1.10 vs $1.18 est
-6.8%
-5.3%
Mixed
Q2 FY2025
$3.2B vs $3.2B est
$1.15 vs $1.11 est
+3.6%
+1.4%
Mixed
Q1 FY2025
$3.2B vs $3.3B est
$1.19 vs $1.23 est
-3.3%
-6.6%
Miss
Q4 FY2024
$3.2B vs $3.4B est
$1.22 vs $1.16 est
+5.2%
-3.2%
Mixed
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Kohlberg Kravis Roberts & CO. L.P.
13.8%
15.7M
$1.3B
+0.0%
Fmr LLC
6.7%
7.6M
$630.9M
+32.0%
Blackrock, INC.
6.2%
7.0M
$586.7M
+0.0%
Artisan Partners Limited Partnership
5.7%
6.5M
$540.2M
-1.6%
Vanguard Capital Management LLC
5.6%
6.3M
$530.1M
-1.2%
Jpmorgan Chase & CO
3.8%
4.3M
$366.4M
-4.8%
State Street Corp
3.7%
4.3M
$359.6M
-1.7%
Vanguard Portfolio Management LLC
3.6%
4.1M
$345.2M
-1.5%
American Century Companies INC
3.0%
3.5M
$288.7M
-3.8%
Dimensional Fund Advisors LP
3.0%
3.4M
$283.5M
+18.1%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
Albertini Andrea
officer: CEO, Global Dist. & Tech.
2026-09-08
Sell
603
$53583
Albertini Andrea
officer: CEO, Global Dist. & Tech.
2026-09-08
Sell
4K
—
DANIEL WILLIAM K
director
2026-06-12
Buy
2K
—
Murphy Kelly Ann
officer: SVP & General Counsel
2026-05-21
Other
0
—
Murphy Kelly Ann
officer: SVP & General Counsel
2026-05-21
Other
1K
$92748
Murphy Kelly Ann
officer: SVP & General Counsel
2026-05-21
Other
9K
$711872
Murphy Kelly Ann
officer: SVP & General Counsel
2026-05-21
Other
3K
$256998
BERGMAN STANLEY M
other: Former Director
2026-05-26
Sell
50
—
What you'll find
Next Henry Schein (HSIC) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Henry Schein reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Henry Schein (HSIC)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Henry Schein's next earnings date?
Henry Schein's (HSIC) next scheduled earnings date is Nov 3, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Henry Schein (HSIC) beat or miss earnings?
In Q2 FY2026, Henry Schein (HSIC) posted beat results — revenue of $3.5B versus the $3.4B estimate (+2.5% surprise) and EPS of $1.27 versus $1.24 expected (+2.4% surprise). Magnisto decodes every Henry Schein (HSIC) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Henry Schein beat earnings estimates?
Over its last 8 reported quarters, Henry Schein (HSIC) beat Wall Street EPS estimates 6 times, most recently a beat result in Q3 FY2026. Magnisto tracks every Henry Schein (HSIC) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Henry Schein stock move after earnings?
Over its last 8 quarterly reports, Henry Schein (HSIC) moved an average of ±4.2% the day after earnings — ranging from -6.6% (Q1 FY2025) to +11.4% (Q4 FY2025). The stock rose after 5 of those 8 reports and fell after 3. Heading into its next report on Nov 3, 2026, options-implied volatility is pricing in a move of roughly ±3.2% (derived). Magnisto tracks the realized post-earnings move for every Henry Schein (HSIC) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of Henry Schein?
Institutions hold about 109.2% of Henry Schein's (HSIC) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Kohlberg Kravis Roberts & CO. L.P. (13.8%), Fmr LLC (6.7%), Blackrock, INC. (6.2%). Magnisto lists Henry Schein's (HSIC) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling Henry Schein (HSIC)?
In the most recent Form 4 filings Magnisto tracks, Henry Schein (HSIC) insiders recorded 2 purchases and 6 sales — net selling. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for Henry Schein (HSIC) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Henry Schein (HSIC), anchored to the current $85.21 share price, so you can weigh the bull, base and bear cases for Henry Schein side by side.
Is Henry Schein (HSIC) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Henry Schein fits your own thesis and risk profile. This is research, not investment advice.